FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

9 letters match. Newest first.

  1. Conceive Fertility Center

    FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.

    High risk
  2. Louisville Reproductive Center

    Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.

    High risk
  3. Akan Biosciences, Inc.

    FDA warned Akan Biosciences over unapproved Ayama injectable and donor-screening failures.

    High risk
  4. Washington Fertility Center

    FDA warned Washington Fertility Center about incomplete donor eligibility screening and testing for oocytes, semen, and embryos.

    High risk
  5. Beckman Coulter Inc.

    FDA warns Beckman Coulter over inadequate quality-system procedures for DxI 9000 immunoassay devices.

    High risk
  6. Mark S. Denker, M.D., PA dba Palm Beach Fertility Center

    FDA warns Boca Raton fertility center over failures to screen sperm and egg donors for infectious disease risk.

    High risk
  7. Zhang Medical P.C. dba New Hope Fertility Center

    New Hope Fertility Center failed to properly screen and test oocyte and semen donors for communicable diseases, FDA says.

    High risk
  8. Kleenhanz, LLC

    FDA told Kleenhanz its antiseptic towelettes were unapproved drugs because the website and Twitter claimed they fight COVID-19 and other diseases.

    High risk
  9. Cooper Institute

    FDA warned Houston fertility clinic Cooper Institute that it failed to test and screen oocyte donors for infectious diseases.

    High risk